George Medicines

George Medicines Signs Korea Deal to Commercialize GMRx2

LONDON, UK, March 11, 2026 George Medicines, a late-stage biopharmaceutical company focused on cardiometabolic diseases, has announced an exclusive...

By cGxPwire Editor
March 13, 2026

Pharma

FDA Clears WIDAPLIK™, Developed with Piramal Pharma Solutions

Piramal Pharma Solutions, a global contract development and manufacturing organization (CDMO), has collaborated with George Medicines to develop WIDAPLIK™,...